SP
ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ·Healthcare·Biotechnology
$2.77
-1.08%
Mkt Cap $263.54M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (10 analysts)
$15.00
Range $15.00 – $15.00
Implied Upside
+442.5%
Consensus $15.00 vs current $2.77
NASDAQ·Healthcare·Biotechnology
$2.77
-1.08%
Mkt Cap $263.54M
Buy
5
Hold
0
Sell
0
Price Target (10 analysts)
$15.00
Range $15.00 – $15.00
+442.5%
Consensus $15.00 vs current $2.77